TNF-α receptor 1 expression on acute myeloid leukemic blasts predicts differentiation into leukemic dendritic cells [7]

Leukemia

Volumn 18, Issue 6, 2004, Pages 1149-1153

  Houtenbos, I ^a   Westers, T M ^a   de Gruijl, T D ^a   Scheper, R J ^a   Ossenkoppele, G J ^a   van de Loosdrecht, A A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 3; INTERLEUKIN 4; STEM CELL FACTOR; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; BLAST CELL; CELL DIFFERENTIATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LETTER; LEUKEMIA CELL; MALE; MIXED LYMPHOCYTE REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ACUTE DISEASE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; PREDICTION AND FORECASTING;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 2942659919     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403359     Document Type: Letter

References (8)

1. Westers TM, Stam AM, Scheper RJ, Regelink JC, Nieuwint AM, Schuurhuis GJ et al. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia. Cancer Immunol Immunother 2003; 52: 17-27.
2. Ossenkoppele GJ, Stam AG, Westers TM, De Gruijl TD, Janssen JJ, Van De Loosdrecht AA et al. Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells. Leukemia 2003; 17: 1424-1426.
3. Houtenbos I, Westers TM, Stam AG, De Gruijl TD, Scheper RJ, Ossenkoppele GJ et al. Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation. Cancer Immunol Immunother 2003; 52: 455-462.
4. Mohty M, Isnardon D, Blaise D, Mozziconacci MJ, Lafage-Pochitaloff M, Briere F et al. Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia 2002; 16: 2267-2274.
5. Re F, Arpinati M, Testoni N, Ricci P, Terragna C, Preda P et al. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage. Exp Hematol 2002; 30: 126-134.
6. Houtenbos I, Westers TM, Ossenkoppele GJ, Van De Loosdrecht AA. Identification of CD14 as a predictor for leukemic dendritic cell differentiation in acute myeloid leukemia. Leukemia 2003; 17: 1683-1684.
7. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127-3131.
8. Santini V, Gozzini A, Scappini B, Rossi FP. Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation. Haematologica 1999; 84: 291-297.